White Plains, New York 10605


Purpose:

Normal adolescence requires a successful resolution of identity crisis, which results in the development of satisfying relationships, success in school/work pursuits, and achievement of personal goals. Adolescents, who do not resolve this crisis, are at high risk for problems in those areas of functioning. Transference Focused Psychotherapy for Adolescents (TFP-A) is a treatment that specifically addresses these issues, permitting adolescents to develop satisfying friendships, more appropriate interactions with authority, and achieve realistic life goals. This study will evaluate the application of TFP-A, (a empirically validated treatment for adults with identity disturbance), to adolescents exhibiting the same behavioral and identity pathology. Subjects will be females; ages 14-21, with behaviors associated with identity problems, interpersonal difficulties with teachers, parents and/or peers, and live with their families. These adolescents will be randomly assigned to one of two treatment cells, TFP-A or Treatment as Usual (TAU). Subjects in TFP-A will receive weekly individual therapy for six months. The TAU group will receive standard individual therapy in the Outpatient Department. Both will receive medication as necessary. All subjects will participate in initial, weekly, and bi-monthly assessments during the six-month treatment period, and participate in a naturalistic follow-up study for an additional six months. Hypothesis: Adolescents with identity problems as seen in interpersonal, school, and/or family difficulties in the Transference Focused Psychotherapy for Adolescents (TFP-A) group will reduce these problem behaviors and improve management of their feelings and moods compared to adolescents with identity problems in the treatment as usual control group (TAU).


Criteria:

Inclusion Criteria: 1. Female Adolescents, ages 14-21 2. A score of five out of nine critical items on the Borderline Personality Disorder Dimension Interview Scale. 3. Have interpersonal difficulties in school, family, and/or peer functioning. 4. Live at home with family. 5. Willingness to attend evaluation sessions and weekly, individual therapy. Exclusion Criteria: 1. The presence of psychosis, substance dependence, non-verbal learning disability, antisocial behavior, and/or primary diagnoses of eating disorder, bipolar disorder, and obsessive-compulsive disorder. 2. The need for hospitalization for symptom management. 3. Significant cognitive impairment (Full Scale IQ <85). 4. The presence of a life-threatening medical illness.


NCT ID:

NCT00571571


Primary Contact:

Principal Investigator
Anna E Odom, Ph.D.
Weill Medical College of Cornell University

Anna E Odom, Ph.D.
Phone: 914-997-5946
Email: ano9021@med.cornell.edu


Backup Contact:

Pamela A Foelsch, Ph.D.
Phone: 212-213-9879


Location Contact:

White Plains, New York 10605
United States

Maura L Lehr, LCSW
Phone: 914-997-5866
Email: mll9001@nyp.org

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: August 17, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.